Literature DB >> 23132179

Perioperative management of pheochromocytoma and catecholamine-induced dilated cardiomyopathy in a pediatric patient.

Yuvraj Kalra1, Hemant S Agarwal, Andrew H Smith.   

Abstract

Dilated cardiomyopathy resulting from pheochromocytoma-mediated catecholamine excess poses a unique challenge to heart failure management. Although early screening of patients with familial neoplastic syndromes at risk for pheochromocytoma may facilitate early resection, the resultant manifestations of prolonged catecholamine excess among patients with undiagnosed pheochromocytoma may lead to myocardial fibrosis with both systolic and diastolic dysfunction. Furthermore, the hemodynamic effects of catecholamine excess exacerbate the risks of perioperative hemodynamic instability in the setting of such myocardial depression. This report describes an approach to the perioperative care of a child who had pheochromocytoma and catecholamine-induced cardiomyopathy with ventricular dysfunction refractory to medical management.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23132179     DOI: 10.1007/s00246-012-0564-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  26 in total

1.  A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.

Authors:  James Dean Sandham; Russell Douglas Hull; Rollin Frederick Brant; Linda Knox; Graham Frederick Pineo; Christopher J Doig; Denny P Laporta; Sidney Viner; Louise Passerini; Hugh Devitt; Ann Kirby; Michael Jacka
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

2.  Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial.

Authors:  Sheila Harvey; David A Harrison; Mervyn Singer; Joanne Ashcroft; Carys M Jones; Diana Elbourne; William Brampton; Dewi Williams; Duncan Young; Kathryn Rowan
Journal:  Lancet       Date:  2005 Aug 6-12       Impact factor: 79.321

3.  Ca overload as the determinant factor in the production of catecholamine-induced myocardial lesions.

Authors:  A Fleckenstein; J Janke; H J Döring; O Pachinger
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1973

4.  Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma.

Authors:  J Imperato-McGinley; T Gautier; K Ehlers; M A Zullo; D S Goldstein; E D Vaughan
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

5.  Catecholamine cardiomyopathy: an unusual presentation of pheochromocytoma in children.

Authors:  M S Schaffer; P Zuberbuhler; G Wilson; V Rose; W J Duncan; R D Rowe
Journal:  J Pediatr       Date:  1981-08       Impact factor: 4.406

Review 6.  von Hippel-Lindau disease.

Authors:  E R Maher; W G Kaelin
Journal:  Medicine (Baltimore)       Date:  1997-11       Impact factor: 1.889

7.  Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection.

Authors:  M A Kinney; M E Warner; J A vanHeerden; T T Horlocker; W F Young; D R Schroeder; P M Maxson; M A Warner
Journal:  Anesth Analg       Date:  2000-11       Impact factor: 5.108

8.  Cerebrovascular event, dilated cardiomyopathy, and pheochromocytoma.

Authors:  Maria I Dagartzikas; Kelly Sprague; Guy Carter; Joseph D Tobias
Journal:  Pediatr Emerg Care       Date:  2002-02       Impact factor: 1.454

9.  Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.

Authors:  G Eisenhofer; M M Walther; T T Huynh; S T Li; S R Bornstein; A Vortmeyer; M Mannelli; D S Goldstein; W M Linehan; J W Lenders; K Pacak
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

10.  A review of clinicopathologic features of pheochromocytomas in Hong Kong Chinese.

Authors:  K Y Lam; A C Chan; W M Wong; K S Lam
Journal:  Eur J Surg Oncol       Date:  1993-10       Impact factor: 4.424

View more
  5 in total

Review 1.  Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.

Authors:  Amrish Jain; Rossana Baracco; Gaurav Kapur
Journal:  Pediatr Nephrol       Date:  2019-01-02       Impact factor: 3.714

Review 2.  Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease?

Authors:  Jenn Rachelle U Santos; Alessandra Brofferio; Bruna Viana; Karel Pacak
Journal:  Horm Metab Res       Date:  2018-09-18       Impact factor: 2.936

3.  Treatment of Hypertension in Children With Catecholamine-Secreting Tumors: A Systematic Approach.

Authors:  Mauricio Romero; Gaurav Kapur; Rossana Baracco; Rudolph P Valentini; Tej K Mattoo; Amrish Jain
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-05-23       Impact factor: 3.738

Review 4.  Review of Pediatric Pheochromocytoma and Paraganglioma.

Authors:  Reshma Bholah; Timothy Edward Bunchman
Journal:  Front Pediatr       Date:  2017-07-13       Impact factor: 3.418

5.  Predictive Factors for Catecholamine-Induced Cardiomyopathy in Patients with Pheochromocytoma and Paraganglioma.

Authors:  Yi Wang; Xuerong Yu; Yuguang Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-08       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.